Postpartum Mh Htn denied for failing step therapy by Humana?

Humana's specific coverage criteria for postpartum mh htn are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Uses Step Therapy for Postpartum Mental Health and Hypertension Medications

Step therapy — sometimes called "fail first" — is a Humana policy that requires you to try one or more lower-cost or preferred medications before it will cover the prescribed treatment. For postpartum mental health and hypertension, Humana's step protocol typically means trying a formulary-preferred medication first and documenting that it either failed to work or caused intolerance. Step-therapy denials are common and are among the most successfully appealed categories when prior treatment history is well-documented.

## Why This Denial Is Appealable — Including Step-Therapy Bypass

Many states have enacted step-therapy reform laws that require insurers to grant a step-therapy exception when: (1) the required step drug was previously tried and failed; (2) the step drug is contraindicated or expected to cause an adverse reaction; (3) the required trial would delay clinically urgent treatment; or (4) the patient is stable on the requested drug and switching would create risk. Federal law and Humana's own coverage policies also contain exception pathways. Postpartum conditions are time-sensitive — requiring a patient to fail a prior-step drug before receiving appropriate care can cause measurable clinical harm, which is a recognized grounds for exception.

## Federal Appeal Framework

• Step-therapy exception request: File this first. Under applicable state step-therapy reform laws and Humana's own policies, you may bypass step requirements with sufficient clinical justification.
• Internal appeal (ERISA §503 / state law): If the exception is denied, file a formal internal appeal within the timeframe on your denial notice.
• External review (ACA §2719): A final internal denial is reviewable by an independent IRO within approximately four months. IROs frequently overturn step-therapy denials where a prescriber has documented prior failure or clinical contraindication.
• Expedited review: Postpartum conditions support an urgency argument — request the expedited track (typically 72 hours) at both levels.

## Documentation to Gather

1. Prior step drug history: For every drug in Humana's step protocol, provide the name, approximate dates of use, and the documented reason it was stopped — inadequate response, intolerance, or clinical contraindication. Chart notes, pharmacy records, and the prescriber's letter are all useful. 2. Clinical urgency documentation: Chart notes explaining why delaying treatment to satisfy step therapy poses clinical risk — particularly relevant in a postpartum context where rapid symptom progression can occur. 3. Prescriber step-therapy exception letter: A letter from your OB/GYN, psychiatrist, or primary care provider addressing each of Humana's step-exception criteria point by point. 4. FDA prescribing label for the requested drug: To confirm the indication and any population-specific guidance relevant to postpartum patients. 5. Humana's step-therapy protocol: Obtain the exact protocol so you know which drugs are required steps and what the exception criteria are.

## Criteria-Mapping Structure

Map Humana's step-exception criteria directly to your documentation:

| Humana Step-Exception Criterion | Your Evidence | |---|---| | Step drug previously tried and failed | [Drug name, dates, chart outcome note] | | Step drug contraindicated / expected adverse effect | [Clinical basis, prescriber letter] | | Treatment delay creates clinical risk | [Prescriber urgency statement, diagnosis severity] | | Patient stable on requested drug (if continuation) | [Current treatment duration, clinical status] |

State your applicable state's step-therapy exception law (if your state has one) in the appeal letter header — this immediately signals to the reviewer that your claim has a statutory foundation.